- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00292383
Ventricular Pacing Site Selection (V-PASS)
A Randomized, Prospective Multicenter Pilot Study to Determine the Influence of the Ventricular Pacing Site on the Incidence of Atrial Fibrillation and Heart Failure in Patients With Indication for Permanent Pacemaker Stimulation Therapy.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
AV-Block of higher degree is the primary indication for pacing therapy for about 20% of pacemaker patients. Pacing systems with only ventricular stimulation (VVI and VDD) have a fraction of about 40% of all pacemakers in Germany. About 50% of the implanted pacemakers in Germany are dual-chamber pacemakers and one half of them is used for treatment of AV blocks.
Picture 1: Fractions of pacing indications in Germany Picture 2: Fractions of used pacing modes in Germany /1/
A lot of studies proved in the past that the pacing site influenced the development of hemodynamics, heart failure (HF) and atrial fibrillation (AF). Unfortunately, the results are not commonly applicable or statistically assured. Due to this, further examinations are required in order to get explicit statements regarding application of alternative, nonapical ventricular lead positioning.
- Pilotphase It shall be determined whether a randomized positioning of ventricular leads at 2 defined positions (either Group A: Positioning at right ventricular apex or Group B:. Positioning at right ventricular high septum) is feasible. Included patients will already by examined and followed according to protocol. After having proved feasibility of randomized positioning, the data of these patients shall be used for evaluation of the V-PASS study.
- Study Phase It shall be evaluated how far 2 defined different ventricular lead positions for permanent pacemaker therapy can influence the combined study endpoint mortality and clinically relevant symptoms of heart failure. Further more the development of hemodynamics and the incidence of atrial fibrillation shall be studied.
Studietyp
Inskrivning (Förväntat)
Fas
- Fas 4
Kontakter och platser
Studiekontakt
- Namn: Matthias E Reimers, Dipl. Documentalist
- Telefonnummer: 422 0049021152930
- E-post: Matthias.reimers@vitatron.com
Studera Kontakt Backup
- Namn: Steffen Gazarek, Dr., Engineer
- Telefonnummer: 004901729135662
- E-post: steffen.gazarek@vitatron.com
Studieorter
-
-
-
Bad Krozingen, Tyskland, D-79189
- Rekrytering
- Herzzentrum Bad Krozingen, Elektrophysiologie
-
Kontakt:
- Jochem Stockinger, MD
- Telefonnummer: 248 0049 07633402
- E-post: JFStockinger@gmx.de
-
Huvudutredare:
- Jochem Stockinger, MD
-
Underutredare:
- Thomas Blum, MD
-
Heidelberg, Tyskland, D-69120
- Har inte rekryterat ännu
- Universitätsklinikum Heidelberg, Innere Medizin III
-
Kontakt:
- Alexander Bauer, MD
- Telefonnummer: 8672 ++49 0622563
- E-post: Alexander.Bauer@med.uni-heidelberg.de
-
Huvudutredare:
- Alexander Bauer, MD
-
Wangen, Tyskland, D-88239
- Har inte rekryterat ännu
- Oberschwaben Klinik GmbH, Krankenhaus Wangen, Innere Med.
-
Kontakt:
- Jörg Maurus, MD
- Telefonnummer: 1311 0049 00752296
-
Huvudutredare:
- Jörg Maurus, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Patients with an expected ventricular stimulation rate of >60% in planned pacing therapy. This will be the following pacing indications
- Symptomatic first-degree AV block, PQ time >250ms
- Second-degree Av block with permanent 2:1 conduction
- Permanent third-degree AV block
- Paroxysmal first-degree to third-degree Av block, with an anticipated rate of ventricular stimulation >60%
- Symptomatic bradyarrhythmia absoluta with permanent atrial fibrillation, with an anticipated rate of ventricular stimulation >60%
Exclusion Criteria:
- heart failure acc. NYHA III or IV
- Intra-atrial conduction delay (P-wave > 150ms)
- Myocardial infarction less then 6 months before pacemaker implant
- hypertrophic obstructive cardiomyopathy
- Cardiogenic shock
- pregnancy
- Lactation period
- Patients under 18 years of age
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
Amount of patients in which the ventricular lead position could be positioned successfully according randomization
|
Sekundära resultatmått
Resultatmått |
---|
Hjärtsvikt
|
Typical values re operation procedure in both groups
|
operation time, x-ray time
|
intraoperative measurements (amplitudes, thresholds)
|
broad QRS-complexes in both groups
|
safety of therapy, complications
|
electrical specific values in both groups
|
energy consumption, lead impedance
|
Rhythmologic characteristics in both groups
|
amount of VESs
|
episodes of ventricular tachycardia
|
amount of atrial and ventricular stimulation
|
BNP-levels in both groups
|
incidence of co-morbidities in both groups
|
Atrial Fibrillation, AF burden >1%
|
Heart failure > NYHA II
|
Hospitalizations in both groups due to
|
Rhythm disorders
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Jochem F. Stockinger, MD, Herzzentrum Bad Krozingen
Publikationer och användbara länkar
Allmänna publikationer
- Giudici MC, Thornburg GA, Buck DL, Coyne EP, Walton MC, Paul DL, Sutton J. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol. 1997 Jan 15;79(2):209-12. doi: 10.1016/s0002-9149(96)00718-7.
- Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002 Jun 13;346(24):1854-62. doi: 10.1056/NEJMoa013040.
- Fachgruppe Herzschrittmacher. Bericht des Deutschen Herzschrittmacher Registers 2003 http://www.pacemaker-register.de/pdf/zentralregister_herzschrittmacher_bericht03.pdf
- DÄNISCHES HERZSCHRITTMACHERREGISTER http://www.pacemaker.dk
- SCHWEIZER HERZSCHRITTMACHERREGISTER http://www.pacemaker.ch
- Lemke B., Nowak B. Pfeiffer D. Leitlinien zur Herzschritmachertherapie. Deutsche Gesellschaft für Kardiologie 2005. http://www.dgk.org/leitlinien/LLHerzschrittmacher.pdf
- Gregoratos G., Abrams J. Epstein AE, et al. ACC/AHA /NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation)(2002). http://www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf
- Frohlig G, Schwaab B, Kindermann M. Selective site pacing: the right ventricular approach. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 2):855-61. doi: 10.1111/j.1540-8159.2004.00547.x.
- Koglek W, Kranig W, Kowalski M, Kronski D, Brandl J, Oberbichler A, Suntinger A, Wutte M, Grimm G, Grove R, Ludorff G. [A simple method for AV-delay determination in dual chamber pacemakers]. Herzschrittmacherther Elektrophysiol. 2000 Dec;11(4):244-53. doi: 10.1007/s003990070023. German.
Studieavstämningsdatum
Studera stora datum
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- V-PASS V.1.2.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Atrioventrikulärt block
-
Kafrelsheikh UniversityAvslutadAnalgesi | Erector Spinae Plane Block | Quadratus Lumborum Block | Paravertebralt blockEgypten
-
Tanta UniversityOkändKonventionellt kaudalt block | Ultraljudsstyrt kaudalt block | Ultraljudsguided Erector Spinae Block | Pediatrisk höftkirurgiEgypten
-
Tanta UniversityHar inte rekryterat ännuInterscalene Block | Ytligt cervikalt blockEgypten
-
Kreiskrankenhaus DormagenAvslutadNeuromuskulärt block, dexametason | Neuromuskulärt block, återhämtningTyskland
-
Tanta UniversityRekryteringErector Spinae Plane Block | Artroskopi | Interscalene BlockEgypten
-
University of Wisconsin, MadisonAvslutadRegionalt block för smärtkontroll | Supraklavikulärt block | Ultraljudsguidad block | BlocktillsatsFörenta staterna
-
The General Authority for Teaching Hospitals and...AvslutadKejsarsnitt | Quadratus Lumborum Block | Transversus Abdominis Plane BlockEgypten
-
Tanta UniversityAvslutadTotal knäprotesplastik | Popliteal Plexus Block | Fascia Iliaca BlockEgypten
-
Zagazig UniversityAvslutadPerikapsulär nervgruppsblock (PENG-block) | Lumbal Erector Spinae Plane BlockEgypten
-
Tanta UniversityAvslutadCaudal Block | Pediatrik | Sacral Erector Spinae Plane Block | PenisoperationerEgypten